Cuba a Beacon of International Solidarity and Medical Excellence in Fight Against COVID-19
Cuban medical team of 50 arrives in Suriname March 20, 2020, to assist
with COVID-19 pandemic.
On March 21, 53 physicians and nurses from Cuba's
celebrated Henry Reeve International Medical Brigade of health
professionals, trained in disaster medicine and infectious disease
containment, arrived in Italy's northern Lombardy region at the request
of its health authorities. They will join a dozen Chinese doctors to
work in a new field hospital being built in Bergamo in Italy's hardest
hit area, where over 63 per cent of the country's deaths due to
COVID-19 and 42 per cent of its active cases are concentrated, with
over 1,000 patients undergoing intensive treatment. It is the sixth
contingent of the specialized brigade to go abroad to fight the
COVID-19 pandemic and the first sent to Europe.
Other contingents of the brigade recently left to
assist a number of countries in the Americas. One hundred forty-four
doctors arrived on the weekend in Jamaica and 136 in Venezuela; five
intensive care nurses recently arrived in Grenada and 51 health care
professionals in Suriname. Those in Venezuela will be part of a group
of 2,000 Cuban doctors working with communities there. Still others are
already at work in Nicaragua. At the moment, Cuba has 28,000 medical
professionals working on missions in 59 countries, the majority of
which are affected by COVID-19.
Cuba's contributions to the fight against the
global pandemic also extends to the scientific investigation taking
place at its Centre for Genetic Engineering and Biotechnology (CIGB) in
Havana where researchers are engaged in numerous studies of the novel
coronavirus SARS-CoV-2 that causes COVID-19, and working on developing
a vaccine for it. In the meantime, many countries have been asking Cuba
to provide them with human recombinant interferon alfa-2b, the
anti-viral medication developed at the centre, which has shown promise
in the treatment of COVID-19 patients in China, south Korea and Germany.
Click to enlarge.
|
A recent report in the online publication Peoples'
Dispatch, reports on the medication's use in combating
COVID-19, calling Cuba "a beacon of international solidarity and
medical excellence in leading the fight against the coronavirus" in
spite of the vicious all-sided blockade the U.S. maintains against it.[1] It says
that the interferon alfa-2b prevented thousands of deaths from the
coronavirus in south Korea and Germany, both of which have reported low
death rates -- especially Germany with a high incidence of the disease
in its population. Given its promise for treating COVID-19, Cuba has
already sent a team of doctors and supplies of interferon alfa-2b to
Italy to work alongside Chinese experts. The medication is also being
used in Panama, Venezuela and elsewhere, with Cuba having produced an
adequate supply for treating thousands of patients at home as well if
necessary.
Cuban-developed interferon alfa-2b has been
produced in China since January 25 as part of a joint venture of the
two countries and is one of 30 drugs chosen by the Chinese National
Health Commission to combat the respiratory disease. It was first
developed in 1986 by a team of researchers from the CIGB and has
benefited thousands of Cuban patients. It is marketed as
Heberon® Alfa R. and has been used as a treatment for HIV-AIDS,
hepatitis B and C, herpes zoster (shingles), dengue and different types
of cancers. The medication increases the natural production of
interferon in the human body and strengthens the immune system of
patients.
Doctor Luis Herrera, one of the creators of
interferon alfa-2b, told teleSUR in an interview that the medication's
main purpose is to avoid complications in patients, especially
vulnerable and older people who are susceptible to or have a poor
immune response.
Members of the Cuban Henry Reeve medical brigade arrive in Nicaragua,
March 18, 2020.
Note
1. "Cuba
leads global efforts against COVID-19 in spite of blockade," Tanya
Wadhwa, Peoples' Dispatch, March 16, 2020.
This article was published in
Volume 50 Number 9 - March 21, 2020
Article Link:
Cuba a Beacon of International Solidarity and Medical Excellence in Fight Against COVID-19
Website: www.cpcml.ca
Email: editor@cpcml.ca
|